Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
GlobeNewswire, Inc.
PRINCETON, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced that management will present at the Guggenheim...
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
GlobeNewswire, Inc.
NEW YORK and TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to improving the treatment landscape in mental health...
Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference
GlobeNewswire, Inc.
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at Guggenheim’s...
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
GlobeNewswire, Inc.
-- Strong U.S. launch momentum for IMCIVREE® (setmelanotide) for acquired hypothalamic obesity (HO) continues with more than 700 patient start forms as of September 30, 2026 -- -- Third quarter 2026 net product revenue from global sales of...
IMS Legal Strategies Continues Life Care Planning Expansion To Support Its Growth Strategy with Addition of Medical & Life Care Consulting Services
GlobeNewswire, Inc.
DALLAS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- IMS Legal Strategies (IMS) announces a new expansion of its fast-growing Life Care Planning services and a continuation of its overall growth strategy, with the acquisition of Medical & Life Care...
IMS Legal Strategies Expands to Include Nurse Case Management To Support Its Growth Strategy with Addition of Medical & Life Care Consulting Services
GlobeNewswire, Inc.
DALLAS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- IMS Legal Strategies (IMS) announces a new expansion of its fast-growing services, and a continuation of its overall growth strategy, with the acquisition of Medical & Life Care Consulting Services (MLCC),...
BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference
GlobeNewswire, Inc.
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for...
Boston Launches Annual Winter Coat Drive For Residents Experiencing Homelessness
City of Boston
Boston Public Health Commission is collecting new coats through early February 2027. Monday, November 2, 2026 - Mayor Michelle Wu, Boston Public Health Commission (BPHC), and Friends of Boston’s Homeless (FOBH) are announcing the launch of their...
Dubai medical team stops infant’s severe seizures with experimental treatment
EIN Presswire
A medical team in Dubai has successfully stopped severe epileptic seizures in an infant who had been experiencing 110 seizures a day DUBAI, UNITED ARAB EMIRATES, November 3, 2026 /EINPresswire.com/ -- A medical team in Dubai has successfully...
ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
GlobeNewswire, Inc.
EINDHOVEN, the Netherlands, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...
Pharmacies Rethink the Workflow: Conveyor Systems Emerge as the Backbone of Modern Pharmaceutical Handling
EIN Presswire
Rising prescription volumes and chronic-care demand are driving pharmacies toward lean, ergonomic, conveyor-assisted fulfillment.
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
GlobeNewswire, Inc.
-- Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon and RM-718 -- -- Rhythm to pay LG Chem additional fixed payments totaling $350 million...
MassTech CEO Recognized by The Women's Edge and Boston Globe as No. 54 Women-Led Business in Massachusetts
Massachusetts Technology Collaborative
BOSTON – Jumping 22 positions, Massachusetts Technology Collaboration (MassTech) CEO Carolyn Kirk was ranked No. 54 by The Women's Edge at Friday’s 2026 Top 100 Women-Led Businesses in Massachusetts celebration.
Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC
GlobeNewswire, Inc.
BOSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that it will...
Tango and Erasca Initiate Phase 1/2 Study of Oral PRMT5 Inhibitor Vopimetostat in Combination with Pan-RAS Molecular Glue ERAS-0015
GlobeNewswire, Inc.
BOSTON and SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to delivering breakthrough targeted therapies that extend and improve the lives of patients with...
Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026
GlobeNewswire, Inc.
BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral...
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire, Inc.
BOSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced it awarded an...
ATTORNEY GENERAL RAOUL SECURES VICTORY BLOCKING IMPLEMENTATION OF UNLAWFUL MEDICAID WORK REQUIREMENT FOR MEDICALLY FRAIL INDIVIDUALS
Office of Illinois Attorney General
Chicago – Attorney General Kwame Raoul secured a decision by the U.S. District Court for the District of Massachusetts finding the Trump administration’s implementation of new Medicaid work requirements under the One Big Beautiful Bill Act to be...
Agentic AI Raises Infrastructure Considerations Around Action Authorization
EIN Presswire
mEinstein explores how human-controlled, revocable permissions can govern AI agents, ensuring every automated action has legitimate authorization.
Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
GlobeNewswire, Inc.
BRISBANE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that the Company’s management team will participate in a fireside chat at the Guggenheim 3rd...
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.